Alaina Nevels
Family · Lexington, KYNPI 1013460526
Payments from drug & device makers
Across 234 payments — averaging $26.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mimedx Group, Inc.$3K
- AbbVie$730
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$416
- Vanda Pharmaceuticals Inc.$307
- SK Life Science, Inc.$219
- Indivior Inc.$212
- plus $2K from 30 others
What the payments were for
- Travel & lodging$2,05533%
- Food & beverage$4,25767%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$6,312 in reported general payments places this provider in the 95th percentile of 4,374 family providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 55 | $56,188 |
| MounjaroTirzepatide | 32 | $37,117 |
| JardianceEmpagliflozin | 14 | $14,078 |
| FarxigaDapagliflozin Propanediol | 21 | $11,786 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 108 | $6,720 |
| EliquisApixaban | 11 | $6,522 |
| SymbicortBudesonide/Formoterol Fumarate | 13 | $3,463 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 55 | $2,078 |
| Gabapentin | 125 | $1,442 |
| Ventolin HfaAlbuterol Sulfate | 14 | $1,064 |
| FenofibrateFenofibrate Nanocrystallized | 44 | $1,051 |
| Tramadol Hcl | 16 | $985 |
| Atorvastatin Calcium | 133 | $925 |
| Omeprazole | 83 | $801 |
| Levothyroxine Sodium | 95 | $737 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $41 | $56,18855 claims |
| Lilly USA, LLCMounjaro | $41 | $37,11732 claims |
| AstraZenecaFarxiga, Symbicort | $31 | $15,24834 claims |
| PfizerEliquis | $15 | $6,52211 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $15 | $73795 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,374 family providers in Kentucky.
Other family in Lexington
- Elizabeth SaltLexington$89K
- Alisha ClemonsLexington$55K
- Timothy SmallwoodLexington$27K
- Lauren MaupinLexington$18K
- Angela CrutcherLexington$16K
- Emily MesserliLexington$13K
- Rhiannon BlackLexington$12K
- Bonnie HillLouisa$372K
- Ashley SnellenElizabethtown$190K
- Smita RanjanLouisville$92K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.